Immune System Involvement and Therapeutic Targets in Alzheimer's Disease: Insights from Transcriptomic Data Analysis

Area of Science:

• Neuroscience
• Immunology
• Computational Biology

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by amyloid plaques and neurofibrillary tangles.
• Early diagnosis of AD is challenging due to symptom onset after significant neuropathology.
• AD pathogenesis involves complex interactions of genetic, environmental, and lifestyle factors.

Purpose of the Study:

• To investigate immune-related gene expression variations in Alzheimer's disease using bioinformatic strategies.
• To identify specific genes and pathways implicated in AD pathophysiology.
• To explore the potential of bioinformatics in discovering novel biomarkers and therapeutic targets for AD.

Main Methods:

• Transcriptomic data analysis from Alzheimer's disease patients and healthy controls.
• Bioinformatic strategies to identify differentially expressed genes (DEGs).
• Pathway enrichment analysis to understand biological functions associated with identified DEGs.

Main Results:

• Identification of key differentially expressed genes (DEGs): HLA-DRB4, CD79A, and FCGR3B.
• These DEGs are involved in critical immunological functions, including antigen processing, immunoglobulin synthesis, and signaling pathways.
• Pathway analysis confirmed significant involvement of the immune system, highlighting pathways related to immune control and signaling.

Conclusions:

• Immune dysregulation is a critical factor in Alzheimer's disease pathophysiology.
• Bioinformatics approaches are valuable for uncovering molecular mechanisms and potential therapeutic targets in AD.
• Findings contribute to a holistic understanding of AD and may inform future integrative medicine strategies.